Possible causes of disparities in the risk and outcomes of COVID-19: Cytomegalovirus and aged immune phenotype
[1] Public Health England. Disparities in the Risk and Outcomes of COVID-19. Wellington House: Public Health England; 2020.
[2] Moss P. “The Ancient and the New”: Is there an Interaction between Cytomegalovirus and SARS-CoV-2 Infection? Immun Ageing 2020;17:14.
[3] Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, et al. Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents. PLoS One 2014;9:e108481.
[4] Smith AP. The Psychology of the Common Cold and Influenza: Implications for COVID-19. Int J Clin Virol 2020;4:27-31.
[5] Aiello A, Dowd J, Jayabalasingham B, Feinstein L, Uddin M, Simanek AM, et al. PTSD is Associated with an Increase in Aged T Cell Phenotypes in Adults Living in Detroit. Psychoneuroendocinology 2016;67:133-41.
[6] Derhovanessian E, Theeten H, Hähnel K, Van Damme P, Cools N, Pawelec G. Cytomegalovirus-associated Accumulation of Late-differentiated CD4 T-cells Correlates with Poor Humoral Response to Influenza Vaccination. Vaccine 2013;31:685-90.
[7] Pawelec G. The Human Immunosenescence Phenotype: Does it exist? Semin Immunopathol 2020;2020:239.
[8] Koff WC, Williams MA. Covid-19 and Immunity in aging Populations a New Research Agenda. N Engl J Med 2020;1:383.
[9] Pawelec G, Weng MA. Can an Effective SARS-Cov-2 Vaccine be Developed for the Older Population? Immun Ageing 2020;17:8.